Targeting OX40: rocatinlimab-a novel therapy for atopic dermatitis

Publication date

2026-01-03

Authors

Atash, Keneshka
Boesjes, Celeste
de Bruin-Weller, MarjoleinORCID 0000-0002-1249-6993ISNI 0000000396350234

Editors

Advisors

Supervisors

Document Type

Comment

Collections

License

taverne

Abstract

Keywords

Taverne, Journal Article

Citation

Atash, K, Boesjes, C M & de Bruin-Weller, M S 2026, 'Targeting OX40 : rocatinlimab-a novel therapy for atopic dermatitis', Lancet (London, England), vol. 407, no. 10523, pp. 4-5. https://doi.org/10.1016/S0140-6736(25)02152-X